Shell Asset Management Co. Has $88,000 Position in U.S. Physical Therapy, Inc. (NYSE:USPH)

Shell Asset Management Co. reduced its position in shares of U.S. Physical Therapy, Inc. (NYSE:USPHGet Rating) by 8.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,091 shares of the company’s stock after selling 107 shares during the quarter. Shell Asset Management Co.’s holdings in U.S. Physical Therapy were worth $88,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in the company. Point72 Hong Kong Ltd purchased a new stake in shares of U.S. Physical Therapy during the third quarter worth $45,000. Legato Capital Management LLC acquired a new position in U.S. Physical Therapy in the 4th quarter worth about $890,000. SG Americas Securities LLC increased its position in U.S. Physical Therapy by 39.5% in the 3rd quarter. SG Americas Securities LLC now owns 16,536 shares of the company’s stock worth $1,257,000 after purchasing an additional 4,686 shares during the last quarter. Daiwa Securities Group Inc. increased its position in U.S. Physical Therapy by 28.7% in the 4th quarter. Daiwa Securities Group Inc. now owns 41,222 shares of the company’s stock worth $3,340,000 after purchasing an additional 9,182 shares during the last quarter. Finally, CenterBook Partners LP acquired a new position in U.S. Physical Therapy in the 3rd quarter worth about $1,327,000. 98.44% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at U.S. Physical Therapy

In other U.S. Physical Therapy news, CFO Carey P. Hendrickson sold 471 shares of the company’s stock in a transaction that occurred on Monday, March 13th. The stock was sold at an average price of $95.80, for a total value of $45,121.80. Following the completion of the transaction, the chief financial officer now owns 14,886 shares of the company’s stock, valued at approximately $1,426,078.80. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other U.S. Physical Therapy news, CFO Carey P. Hendrickson sold 471 shares of the company’s stock in a transaction that occurred on Monday, March 13th. The stock was sold at an average price of $95.80, for a total value of $45,121.80. Following the completion of the transaction, the chief financial officer now owns 14,886 shares of the company’s stock, valued at approximately $1,426,078.80. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Richard Binstein sold 911 shares of the stock in a transaction that occurred on Thursday, March 2nd. The stock was sold at an average price of $100.78, for a total value of $91,810.58. Following the completion of the transaction, the executive vice president now directly owns 9,906 shares of the company’s stock, valued at $998,326.68. The disclosure for this sale can be found here. Insiders sold a total of 4,814 shares of company stock valued at $484,853 in the last quarter. Corporate insiders own 1.80% of the company’s stock.

U.S. Physical Therapy Stock Performance

USPH opened at $110.82 on Friday. The company has a market cap of $1.45 billion, a PE ratio of 51.31, a price-to-earnings-growth ratio of 4.35 and a beta of 1.35. The stock has a 50-day moving average of $101.21 and a 200-day moving average of $93.97. U.S. Physical Therapy, Inc. has a 52-week low of $73.30 and a 52-week high of $131.50. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.30 and a current ratio of 1.30.

U.S. Physical Therapy (NYSE:USPHGet Rating) last announced its earnings results on Wednesday, May 3rd. The company reported $0.59 earnings per share for the quarter, beating the consensus estimate of $0.52 by $0.07. U.S. Physical Therapy had a return on equity of 10.93% and a net margin of 5.40%. The firm had revenue of $148.51 million during the quarter, compared to the consensus estimate of $140.77 million. During the same quarter in the prior year, the company earned $0.65 EPS. The firm’s revenue for the quarter was up 12.8% compared to the same quarter last year. As a group, equities research analysts forecast that U.S. Physical Therapy, Inc. will post 2.63 earnings per share for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, June 9th. Investors of record on Thursday, May 18th will be paid a dividend of $0.43 per share. The ex-dividend date of this dividend is Wednesday, May 17th. This represents a $1.72 annualized dividend and a yield of 1.55%. U.S. Physical Therapy’s payout ratio is 79.63%.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on USPH shares. StockNews.com raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research report on Thursday, May 4th. Barrington Research upped their price target on U.S. Physical Therapy from $110.00 to $116.00 in a research note on Friday, May 5th. Finally, TheStreet upgraded U.S. Physical Therapy from a “c+” rating to a “b-” rating in a research note on Friday, May 5th.

About U.S. Physical Therapy

(Get Rating)

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics, which provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries. It operates through the following segments: physical therapy operations and industrial injury prevention services.

See Also

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.